| RS1564106503 |
ZNF462
|
Health Risk |
Likely pathogenic |
— |
| RS1564110292 |
ELP1
|
Health Risk |
Pathogenic/Likely pathogenic |
Medulloblastoma, Medulloblastoma |
| RS1564113368 |
WHRN
|
Health Risk |
Pathogenic/Likely pathogenic |
Deafness, Hearing loss |
| RS1564123602 |
INVS
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS1564131885 |
C5
|
Health Risk |
Likely pathogenic |
— |
| RS1564136499 |
SYNE1
|
Health Risk |
Pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS1564143881 |
LMX1B
|
Health Risk |
Likely pathogenic |
Nail-patella syndrome, Nail-patella syndrome |
| RS1564145502 |
GLE1
|
Health Risk |
Pathogenic/Likely pathogenic |
Lethal congenital contracture syndrome 1, Lethal arthrogryposis-anterior horn cell disease syndrome |
| RS1564146922 |
NR5A1
|
Health Risk |
Likely pathogenic |
46, XY disorder of sex development |
| RS1564150329 |
NR5A1
|
Health Risk |
Pathogenic |
46, XY disorder of sex development |
| RS1564153753 |
NR5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
46, XX sex reversal 4 |
| RS1564157745 |
GABBR2
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 59 |
| RS1564161224 |
TGFBR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS1564161322 |
TGFBR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Isolated thoracic aortic aneurysm |
| RS1564161544 |
TGFBR1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Loeys-Dietz syndrome 1 |
| RS1564165829 |
INVS
|
Health Risk |
Conflicting classifications of pathogenicity |
Infantile nephronophthisis, Nephronophthisis |
| RS1564169730 |
LMX1B
|
Health Risk |
Pathogenic |
Nail-patella syndrome, Nail-patella syndrome |
| RS1564171882 |
INVS
|
Health Risk |
Pathogenic |
Nephronophthisis, Nephronophthisis |
| RS1564177022 |
INVS
|
Health Risk |
Pathogenic/Likely pathogenic |
Nephronophthisis, Infantile nephronophthisis |
| RS1564180346 |
GFI1B
|
Health Risk |
Pathogenic |
Storage pool disease of platelets, Storage pool disease of platelets |
| RS1564191302 |
NOTCH1
|
Health Risk |
Pathogenic |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS1564191682 |
COL5A1
|
Health Risk |
Pathogenic |
— |
| RS1564191704 |
COL5A1
|
Health Risk |
Pathogenic |
Ehlers-Danlos syndrome, classic type |
| RS1564193130 |
INVS
|
Health Risk |
Pathogenic |
— |
| RS1564197227 |
SPTAN1
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 5 |
| RS1564199476 |
NOTCH1
|
Health Risk |
Pathogenic |
Adams-Oliver syndrome 5, Adams-Oliver syndrome 5 |
| RS1564202579 |
PTPA
|
Health Risk |
Pathogenic |
Parkinson disease 25, autosomal recessive early-onset |
| RS1564217246 |
TRIM32
|
Health Risk |
Pathogenic/Likely pathogenic |
Bardet-Biedl syndrome 11, Sarcotubular myopathy |
| RS1564218190 |
TRIM32
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS1564228101 |
ANKS6
|
Health Risk |
Pathogenic |
Nephronophthisis 16, Nephronophthisis 16 |
| RS1564229174 |
FRRS1L
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 37 |
| RS1564229228 |
FRRS1L
|
Health Risk |
Likely pathogenic |
Developmental and epileptic encephalopathy, 37 |
| RS1564232243 |
FRRS1L
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 37 |
| RS1564236717 |
ANKS6
|
Health Risk |
Pathogenic |
Nephronophthisis 16, Nephronophthisis 16 |
| RS1564249350 |
WHRN
|
Health Risk |
Pathogenic |
— |
| RS1564278864 |
MAN1B1
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1564281411 |
MAN1B1
|
Health Risk |
Pathogenic |
Rafiq syndrome, Rafiq syndrome |
| RS1564281463 |
MAN1B1
|
Health Risk |
Pathogenic |
Rafiq syndrome, Rafiq syndrome |
| RS1564282020 |
SPTAN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Early-infantile DEE, Early-infantile DEE |
| RS1564284467 |
FKTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Walker-Warburg congenital muscular dystrophy, Walker-Warburg congenital muscular dystrophy |
| RS1564286708 |
SPTAN1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 5 |
| RS1564287793 |
LRSAM1
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease axonal type 2P, Charcot-Marie-Tooth disease |
| RS1564287871 |
LRSAM1
|
Health Risk |
Likely pathogenic |
Charcot-Marie-Tooth disease axonal type 2P, Charcot-Marie-Tooth disease axonal type 2P |
| RS1564290079 |
AGPAT2
|
Health Risk |
Pathogenic |
Congenital generalized lipodystrophy type 1, Congenital generalized lipodystrophy type 1 |
| RS1564290459 |
FKTN
|
Health Risk |
Pathogenic |
Walker-Warburg congenital muscular dystrophy, Walker-Warburg congenital muscular dystrophy |
| RS1564290914 |
AGPAT2
|
Health Risk |
Pathogenic |
Congenital generalized lipodystrophy type 1, Congenital generalized lipodystrophy type 1 |
| RS1564297234 |
GRHPR
|
Health Risk |
Likely pathogenic |
Primary hyperoxaluria, type II |
| RS1564300408 |
GRHPR
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary hyperoxaluria, type II |
| RS1564300888 |
GRHPR
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary hyperoxaluria, type II |
| RS1564301594 |
FKTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Walker-Warburg congenital muscular dystrophy, Cardiovascular phenotype |
| RS1564304413 |
GPAA1
|
Health Risk |
Likely pathogenic |
— |
| RS1564307664 |
RPL35
|
Health Risk |
Pathogenic |
Diamond-Blackfan anemia 19, Diamond-Blackfan anemia 19 |
| RS1564311909 |
MAN1B1
|
Health Risk |
Pathogenic |
Rafiq syndrome, Rafiq syndrome |
| RS1564313667 |
SHARPIN
|
Health Risk |
Pathogenic |
Autoinflammation with episodic fever and immune dysregulation, Autoinflammation with episodic fever and immune dysregulation |
| RS1564315398 |
SPTAN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 5 |
| RS1564325733 |
POMT1
|
Health Risk |
Pathogenic |
Dysgenesis of the cerebellar vermis, Dysgenesis of the cerebellar vermis |
| RS1564326640 |
FXN
|
Health Risk |
Likely pathogenic |
— |
| RS1564328617 |
DNM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Developmental and epileptic encephalopathy |
| RS1564332930 |
DNM1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 31A |
| RS1564333757 |
STXBP1
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1564336750 |
POMT1
|
Health Risk |
Likely pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A1 |
| RS1564338190 |
CDK5RAP2
|
Health Risk |
Likely pathogenic |
— |
| RS1564340685 |
GRIN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, Neurodevelopmental disorder with or without hyperkinetic movements and seizures |
| RS1564341846 |
POMT1
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1 |
| RS1564346538 |
STXBP1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS1564349087 |
SURF1
|
Health Risk |
Likely pathogenic |
Leigh syndrome, Leigh syndrome |
| RS1564349176 |
SURF1
|
Health Risk |
Pathogenic |
Leigh syndrome, Leigh syndrome |
| RS1564349850 |
STXBP1
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1564351084 |
STXBP1
|
Health Risk |
Pathogenic |
— |
| RS1564351103 |
STXBP1
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1564351269 |
SURF1
|
Health Risk |
Likely pathogenic |
Leigh syndrome, Leigh syndrome |
| RS1564351388 |
STXBP1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS1564352002 |
STXBP1
|
Health Risk |
Pathogenic |
Early-infantile DEE, Early-infantile DEE |
| RS1564354299 |
KCNT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 14 |
| RS1564354968 |
OPTN
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 12, Primary open angle glaucoma |
| RS1564355393 |
DNM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Developmental and epileptic encephalopathy, 31A |
| RS1564355614 |
STXBP1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS1564355642 |
STXBP1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS1564356269 |
STXBP1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS1564357089 |
STXBP1
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 4 |
| RS1564360451 |
OPTN
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1564360978 |
SET
|
Health Risk |
Likely pathogenic |
Intellectual disability, autosomal dominant 58 |
| RS1564363665 |
GRIN1
|
Health Risk |
Likely pathogenic |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS1564364189 |
GRIN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS1564364615 |
POMT1
|
Health Risk |
Pathogenic |
Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B1 |
| RS1564365123 |
OPTN
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 12, Primary open angle glaucoma |
| RS1564365317 |
POMT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2K, Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability) |
| RS1564365418 |
GRIN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neurodevelopmental disorder with or without hyperkinetic movements and seizures, autosomal dominant |
| RS1564365706 |
LAMC3
|
Health Risk |
Pathogenic |
Occipital pachygyria and polymicrogyria, Occipital pachygyria and polymicrogyria |
| RS1564367104 |
SYNE1
|
Health Risk |
Pathogenic |
Autosomal recessive ataxia, Beauce type |
| RS1564367364 |
CARD9
|
Health Risk |
Pathogenic |
Predisposition to invasive fungal disease due to CARD9 deficiency, Predisposition to invasive fungal disease due to CARD9 deficiency |
| RS1564367605 |
KCNT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental and epileptic encephalopathy, 14 |
| RS1564368059 |
LAMC3
|
Health Risk |
Likely pathogenic |
— |
| RS1564371083 |
LAMC3
|
Health Risk |
Likely pathogenic |
— |
| RS1564375476 |
LAMC3
|
Health Risk |
Pathogenic |
— |
| RS1564378996 |
CRB2
|
Health Risk |
Pathogenic |
— |
| RS1564379463 |
CUBN
|
Health Risk |
Likely pathogenic |
Imerslund-Grasbeck syndrome, Imerslund-Grasbeck syndrome |
| RS1564381395 |
POMT1
|
Health Risk |
Likely pathogenic |
Autosomal recessive limb-girdle muscular dystrophy type 2K, Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies) |
| RS1564385081 |
DHTKD1
|
Health Risk |
Conflicting classifications of pathogenicity |
2-aminoadipic 2-oxoadipic aciduria, Charcot-Marie-Tooth disease type 2A2 |
| RS1564386891 |
TPRN
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 79, Autosomal recessive nonsyndromic hearing loss 79 |